A MEDICAL technologies and devices manufacturer employing more than 650 people in Deeside, has welcomed the local Member of Parliament.
Alyn and Deeside MP Mark Tami visited Convatec on Deeside Industrial Park for an update on developments since his last visit.
Convatec has had a significant presence in Deeside since 1982. The company's chief financial officer Jonny Mason and UK manufacturing site leader Adeel Mushtaq hosted the visit. Mr Tami also met leaders in the firm's research and development and operations teams, as well as several of the company's apprentices and summer interns.
He was given a demonstration of Convatec's different products in advanced wound care and a tour of the facilities, including new automated textile lines and expanded clean room.
From left: Ashley Sweetland, VP global corporate affairs; CFO Jonny Mason; Clare Holden, VP, R&D; Mark Tami MP; Gary Pearson, Focus Factory Lead, manufacturing; Adeel Mushtaq, UK manufacturing director; and Richard Sylvester, advanced operations
Mr Tami said: "I'm impressed to see the level of investment that Convatec continues to make in UK life sciences manufacturing here in Deeside, and pleased that the company employs more than 650 people in the local area in high-quality jobs.
"I was also interested to hear more about its engineering apprenticeship programme, working with Coleg Cambria, and Convatec's new sustainability internship programme."
Read more:
- Engineers from AMRC play key role in race for Paralympic gold
- Theatr Clwyd redevelopment to create 100 jobs and boost North Wales economy
The FTSE 100 company has been operating from its Deeside facilities for more than 40 years, where it produces over 100 million dressings and innovative solutions for advanced wound care every year.
Mr Mason said: "We were very pleased to welcome back Mark to the site. Our teams are rightly proud to showcase our leading Convatec Advanced Wound Care production facilities in his constituency, which have been part of the local community since 1982.
"We are grateful to Mark for his time and the opportunity to share more about Convatec's significant investment in the UK life sciences industry, including the progress we have made in automation, and to discuss our exciting product pipeline and future plans."
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here